S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Creatd (CRTD) Insider Trading & Ownership

$1.80
0.00 (0.00%)
(As of 04/19/2024 ET)

Creatd (NASDAQ:CRTD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
11.76%
Number Of
Insiders Buying
(Last 3 Years)
4
Amount Of
Insider Buying
(Last 3 Years)
$592,401.65
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$6.39 M
Get CRTD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Creatd stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CRTD Insider Buying and Selling by Quarter

Creatd Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/29/2022Jeremy FrommerChairmanBuy2,839$0.57$1,618.23  
8/25/2022Jeremy FrommerChairmanBuy5,442$0.62$3,374.04  
8/16/2022Jeremy FrommerChairmanBuy1,950$0.76$1,482.00  
8/11/2022Jeremy FrommerChairmanBuy1,304$0.72$938.88  
8/8/2022Jeremy FrommerChairmanBuy1,266$0.72$911.52  
8/5/2022Jeremy FrommerChairmanBuy1,384$16.81$23,265.04  
8/3/2022Jeremy FrommerChairmanBuy1,165$0.69$803.85  
8/1/2022Jeremy FrommerChairmanBuy5,612$0.73$4,096.76  
7/1/2022Jeremy FrommerChairmanBuy4,331$0.72$3,118.32  
6/23/2022Jeremy FrommerChairmanBuy1,807$0.77$1,391.39  
6/13/2022Jeremy FrommerChairmanBuy1,247$0.84$1,047.48  
6/10/2022Jeremy FrommerChairmanBuy1,031$0.90$927.90  
5/27/2022Jeremy FrommerChairmanBuy3,304$1.06$3,502.24  
5/17/2022Jeremy FrommerChairmanBuy2,330$0.74$1,724.20  
4/27/2022Jeremy FrommerChairmanBuy3,034$0.94$2,851.96  
4/20/2022Jeremy FrommerChairmanBuy1,026$1.07$1,097.82  
4/18/2022Jeremy FrommerChairmanBuy1,116$1.24$1,383.84  
4/14/2022Jeremy FrommerChairmanBuy1,552$1.19$1,846.88  
4/11/2022Jeremy FrommerChairmanBuy3,463$0.98$3,393.74  
4/8/2022Jeremy FrommerChairmanBuy1,605$1.04$1,669.20  
4/6/2022Chelsea PullanoCFOBuy35,000$0.01$350.00  
4/6/2022Jeremy FrommerChairmanBuy5,741$1.01$5,798.41  
4/6/2022Laurie WeisbergCEOBuy50,000$0.00$0.00  
3/9/2022Chelsea PullanoCFOBuy571$1.74$993.54  
3/9/2022Jeremy FrommerChairmanBuy14,286$1.74$24,857.64  
3/9/2022Justin Fontaine MauryCOOBuy1,429$1.74$2,486.46  
3/9/2022Laurie WeisbergCEOBuy5,714$1.74$9,942.36  
3/1/2022Chelsea PullanoCFOBuy1,429$1.75$2,500.75  
3/1/2022Jeremy FrommerDirectorBuy180,000$1.75$315,000.00  
3/1/2022Justin Fontaine MauryCOOBuy5,714$1.75$9,999.50  
3/1/2022Laurie WeisbergCEOBuy28,571$1.75$49,999.25  
1/24/2022Laurie WeisbergCEOBuy2,000$1.68$3,360.00  
1/20/2022Justin Fontaine MauryCOOBuy500$2.06$1,030.00  
1/18/2022Jeremy FrommerCEOBuy1,230$2.03$2,496.90  
1/13/2022Jeremy FrommerCEOBuy2,304$2.17$4,999.68  
1/11/2022Jeremy FrommerCEOBuy2,275$2.20$5,005.00  
1/11/2022Justin Fontaine MauryCOOBuy697$2.13$1,484.61  
1/6/2022Jeremy FrommerCEOBuy4,300$2.19$9,417.00  
1/4/2022Jeremy FrommerCEOBuy7,500$2.25$16,875.00  
12/17/2021Jeremy FrommerCEOBuy526$2.28$1,199.28  
Tiny Biotech Stock Wins $75 Billion Patent (Ad)

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>
12/13/2021Jeremy FrommerCEOBuy460$2.17$998.20  
12/9/2021Jeremy FrommerCEOBuy1,046$2.39$2,499.94  
12/7/2021Jeremy FrommerCEOBuy427$2.34$999.18  
12/2/2021Justin Fontaine MauryCOOBuy397$2.29$909.13  
11/26/2021Jeremy FrommerCEOBuy1,500$2.42$3,630.00  
11/23/2021Laurie WeisbergCEOBuy4,000$2.40$9,600.00  
10/12/2021Laurie WeisbergCEOBuy900$2.18$1,962.00  
9/22/2021Justin Fontaine MauryCOOBuy321$3.21$1,030.41  
9/22/2021Laurie WeisbergCEOBuy1,000$3.11$3,110.00  
9/2/2021Jeremy FrommerCEOBuy500$3.39$1,695.00  
8/31/2021Jeremy FrommerCEOBuy1,000$2.79$2,790.00  
8/23/2021Jeremy FrommerCEOBuy1,200$2.93$3,516.00  
8/18/2021Jeremy FrommerCEOBuy500$2.88$1,440.00  
8/16/2021Justin Fontaine MauryPresidentBuy507$2.96$1,500.72  
8/16/2021Laurie WeisbergCOOBuy2,000$2.97$5,940.00  
8/13/2021Jeremy FrommerCEOBuy2,200$3.11$6,842.00  
7/15/2021Eric GoldbergMajor ShareholderSell206,397$3.61$745,093.17  
7/13/2021Eric GoldbergMajor ShareholderSell983,287$5.74$5,644,067.38  
5/18/2021Jeremy FrommerCEOBuy3,333$3.00$9,999.00  
4/19/2021Jeremy FrommerCEOBuy1,652$3.45$5,699.40  
(Data available from 1/1/2013 forward)

CRTD Insider Trading Activity - Frequently Asked Questions

Who is on Creatd's Insider Roster?
What percentage of Creatd stock is owned by insiders?

11.76% of Creatd stock is owned by insiders. Learn more on CRTD's insider holdings.

Which Creatd insiders have been buying company stock?

The following insider purchased CRTD shares in the last 24 months: Jeremy Frommer ($52,151.63).

How much insider buying is happening at Creatd?

Insiders have purchased a total of 39,072 CRTD shares in the last 24 months for a total of $52,151.63 bought.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:CRTD) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners